In addition, there is a study demonstrating that FAK inhibition could rescue the efficacy of radiotherapy, leading to tumor regression, T-cell priming, and enhanced long-term survival in PDAC mouse models [197]. This evidence concerns the gene PTK2 and neoplasm.